A Randomized, Double Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Curene® versus Placebo in Reducing Symptoms of Knee OA

Table 3

Baseline characteristics.

Efficacy Parameter	Curene®	Placebo
	(N=25)	(N=25)
VAS (in mm)	52.37±6.41	52.79±4.47
WOMAC (Total)	37.88±4.14	37.36±4.08
WOMAC Subscale
Stiffness	4.52±0.92	4.72±1.02
Pain	8.24±1.56	8.16±1.21
Physical Function	25.12±2.21	24.48±2.71